Additionally, the anti‐tumourigenic effect of ERβ in cancer cells could be a combination of downregulation of oncogenes such as PROX1, Myc, and MYB along with increased DNA repair capacity and induction of apoptosis (Figure 2). This evidence concerns the gene ESR2 and cancer.